001     291934
005     20241212090134.0
024 7 _ |a 10.1093/neuonc/noae128
|2 doi
024 7 _ |a pmid:39073785
|2 pmid
024 7 _ |a 1522-8517
|2 ISSN
024 7 _ |a 1523-5866
|2 ISSN
024 7 _ |a altmetric:165778120
|2 altmetric
037 _ _ |a DKFZ-2024-01546
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Liu, Anthony P Y
|0 0000-0002-8597-9128
|b 0
245 _ _ |a SNO-EANO-EURACAN consensus on management of pineal parenchymal tumors.
260 _ _ |a Oxford
|c 2024
|b Oxford Univ. Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1733990476_6794
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2024 Dec 5;26(12):2159-2173
520 _ _ |a Pineal parenchymal tumors are rare neoplasms for which evidence-based treatment recommendations are lacking. These tumors vary in biology, clinical characteristics, and prognosis, requiring treatment that ranges from surgical resection alone to intensive multimodal antineoplastic therapy. Recently, international collaborative studies have shed light on the genomic landscape of these tumors, leading to refinement in molecular-based disease classification in the 5th edition of the World Health Organization (WHO) classification of tumors of the central nervous system. In this review, we summarize the literature on diagnostic and therapeutic approaches, and suggest pragmatic recommendations for the clinical management of patients presenting with intrinsic pineal region masses including parenchymal tumors (pineocytoma, pineal parenchymal tumor of intermediate differentiation, and pineoblastoma), pineal cyst, and papillary tumors of the pineal region.
536 _ _ |a 312 - Funktionelle und strukturelle Genomforschung (POF4-312)
|0 G:(DE-HGF)POF4-312
|c POF4-312
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a clinical treatment guidelines
|2 Other
650 _ 7 |a papillary tumor of pineal region
|2 Other
650 _ 7 |a pineal cyst
|2 Other
650 _ 7 |a pineal parenchymal tumors
|2 Other
650 _ 7 |a risk-stratification
|2 Other
700 1 _ |a Li, Bryan K
|b 1
700 1 _ |a Vasiljevic, Alexandre
|b 2
700 1 _ |a Dewan, Michael C
|b 3
700 1 _ |a Tamrazi, Benita
|b 4
700 1 _ |a Ertl-Wagner, Birgit
|0 0000-0002-7896-7049
|b 5
700 1 _ |a Hansford, Jordan R
|b 6
700 1 _ |a Pfaff, Elke
|0 P:(DE-He78)c0538fae462bd98e3cd8d54ed885b0eb
|b 7
|u dkfz
700 1 _ |a Mynarek, Martin
|0 0000-0003-3302-2719
|b 8
700 1 _ |a Ng, Ho-Keung
|b 9
700 1 _ |a Tsang, Derek S
|b 10
700 1 _ |a Gottardo, Nicholas G
|b 11
700 1 _ |a Gajjar, Amar
|b 12
700 1 _ |a Bouffet, Eric
|0 0000-0002-6832-6539
|b 13
700 1 _ |a Dufour, Christelle
|0 0000-0001-5993-8077
|b 14
700 1 _ |a Pizer, Barry
|b 15
700 1 _ |a Schiff, David
|0 0000-0003-1561-9220
|b 16
700 1 _ |a Jenkinson, Michael D
|b 17
700 1 _ |a Lombardi, Giuseppe
|0 0000-0003-1316-2132
|b 18
700 1 _ |a Wen, Patrick Y
|b 19
700 1 _ |a van den Bent, Martin J
|0 0000-0001-5710-5127
|b 20
700 1 _ |a Huang, Annie
|b 21
773 _ _ |a 10.1093/neuonc/noae128
|g p. noae128
|0 PERI:(DE-600)2094060-9
|n 12
|p 2159-2173
|t Neuro-Oncology
|v 26
|y 2024
|x 1522-8517
909 C O |p VDB
|o oai:inrepo02.dkfz.de:291934
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)c0538fae462bd98e3cd8d54ed885b0eb
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-312
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Funktionelle und strukturelle Genomforschung
|x 0
914 1 _ |y 2024
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-10-24
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NEURO-ONCOLOGY : 2022
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-24
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-24
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-10-24
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b NEURO-ONCOLOGY : 2022
|d 2023-10-24
920 1 _ |0 I:(DE-He78)B360-20160331
|k B360
|l Pädiatrische Gliomforschung
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B360-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21